A Phase 3 Study of elacestrant versus standard endocrine therapy in node-positive ER+, HER2- early breast cancer with high risk of recurrence (ELEGANT)

A Phase 3 Study of elacestrant versus standard endocrine therapy in node-positive ER+, HER2- early breast cancer with high risk of recurrence (ELEGANT)

Trial Category:
Breast
Phase
III
Contact(s)
Kailash Mosalpuria, MD, MPH, FACP
Phone
402-484-4900
Fax
402-991-8850

Dr. Kailash Mosalpuria

402-484-4900

Bryan Medical Center

4004 Pioneer Woods Drive

Lincoln, NE 68506

https://clinicaltrials.gov/study/NCT06492616?cond=elacestrant&page=2&rank=16#contacts-and-locations

 
 
Become a NOS Member Today!
 

Platinum Corporate Members

Gold Corporate Members